These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 15347083)
1. [HbA1c is too high despite tablets. With single injections toward better blood glucose values]. MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347083 [No Abstract] [Full Text] [Related]
2. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes. Ann Intern Med; 2008 Oct; 149(8):I-46. PubMed ID: 18936498 [No Abstract] [Full Text] [Related]
3. [Insulin glargine. The most studied basal insulin]. Walter M MMW Fortschr Med; 2013 Nov; 155(19):70-1. PubMed ID: 24475676 [No Abstract] [Full Text] [Related]
4. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?]. MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711 [No Abstract] [Full Text] [Related]
5. [Insulin therapy in type 2 diabetes]. Hummel M MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497 [No Abstract] [Full Text] [Related]
6. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial. Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501 [TBL] [Abstract][Full Text] [Related]
7. [Therapy with incretin mimetic exenatide. Soon HbA1c value and weight decrease permanently]. MMW Fortschr Med; 2006 Sep; 148(37):55. PubMed ID: 17036908 [No Abstract] [Full Text] [Related]
8. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents. Jacober SJ; Scism-Bacon JL; Zagar AJ Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752 [TBL] [Abstract][Full Text] [Related]
9. [American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success]. MMW Fortschr Med; 2005 Aug; 147(33-34):44-5. PubMed ID: 16138636 [No Abstract] [Full Text] [Related]
10. [Early insulin treatment in type 2 diabetes--yes]. Schumm-Draeger PM Dtsch Med Wochenschr; 2013 May; 138(18):956. PubMed ID: 23613375 [No Abstract] [Full Text] [Related]
11. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study. Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774 [TBL] [Abstract][Full Text] [Related]
13. ["Very good metabolic control by early insulin administration"]. Schumm-Draeger PM MMW Fortschr Med; 2012 Jun; 154(12):25. PubMed ID: 22880291 [No Abstract] [Full Text] [Related]
14. Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes? Ann Intern Med; 2011 Jan; 154(2):I-40. PubMed ID: 21135289 [No Abstract] [Full Text] [Related]
15. Starting insulin therapy in type 2 diabetes: lesson 1. McCall AL Curr Diab Rep; 2005 Oct; 5(5):325-6. PubMed ID: 16188164 [No Abstract] [Full Text] [Related]